Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study
Michela Antonelli, Rose Penfold, Liane S. Canas, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 506-515
Open Access | Times Cited: 22
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
Edward P K Parker, Elsie Horne, William Hulme, et al.
The Lancet Regional Health - Europe (2023) Vol. 30, pp. 100636-100636
Open Access | Times Cited: 14
Factors Associated with Cognitive Impairment in Patients with Persisting Sequelae of COVID-19
Aaron Bonner‐Jackson, Rohun Vangal, Yadi Li, et al.
The American Journal of Medicine (2024)
Closed Access | Times Cited: 6
Maximizing the value of life course studies
Nicholas J. Timpson, Claire J. Steves
Oxford University Press eBooks (2025), pp. 101-118
Closed Access
Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality
Natalie Bennett, Clare Bambra, David R. Sinclair, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e085195-e085195
Open Access
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 8
Vaccinia Virus Strain Mva Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
(2023)
Open Access | Times Cited: 6
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
Anna M. Zhang, Ahmed Elmoursi, Daniel DiGiacomo, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100234-100234
Open Access | Times Cited: 2
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: a systematic review
María Consuelo Bachmann, Nejla Gültekin, Zeno Stanga, et al.
New Microbes and New Infections (2024) Vol. 63, pp. 101551-101551
Open Access | Times Cited: 2
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
Sharon Walmsley, Majid Nabipoor, Leif E. Lovblom, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 36-36
Open Access | Times Cited: 4
Seroprevalence of Anti-SARS-Cov-2 Antibodies among Patients Visiting Hospital-Based Sentinel Sites in the Rift Valley Region, Kenya
Vincent Kiplangat Ruttoh, Brian Kipkoech, Ronald Tonui, et al.
(2024)
Open Access | Times Cited: 1
SCORE: Serologic Evidence of COVID-19, Social, and Occupational Contacts in Healthcare Workers in a Sample of Long-Term Care and Acute Care Facilities in Southeastern Ontario (SCORE)
Jorge Martínez-Cajas, Beatriz Alvarado, Ann Jolly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults
Suad Hannawi, Alaa Abuquta, Linda Saf Eldin, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1109-1109
Open Access | Times Cited: 1
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment
Matteo Augello, Isabell Wagenhäuser, Manuel Krone, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126184-126184
Closed Access | Times Cited: 1
Anti‐Spike IgG antibodies as correlates of protection against SARS‐CoV‐2 infection in the pre‐Omicron and Omicron era
Lisa Seekircher, Manfred Astl, Lena Tschiderer, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access | Times Cited: 1
Association between long-term exposure to air pollutants with breakthrough SARS-CoV-2 infections and antibody responses among COVID-19 vaccinated older adults in northern Italy
Giovanni Veronesi, Francesco Gianfagna, Marianna Karachaliou, et al.
Environmental Research (2024), pp. 120450-120450
Open Access | Times Cited: 1
Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection
Noelia Flor, María I. Rodríguez García, Ana Molineri, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7206-7211
Closed Access | Times Cited: 3
Anti-SARS-CoV-2 IgG Antibody Response in Individuals Infected Post Complete Vaccination: A 6-Month Longitudinal Study in Healthcare Professionals
Nicole Baratto, Lorenza Maistrello, E.P. Pazienza, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1077-1077
Open Access | Times Cited: 2
Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination
Michael Asamoah-Boaheng, Brian Grunau, Scott Haig, et al.
Access Microbiology (2023) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Behçet's patients' response to COVID-19 vaccination
Bindi Gokani, Sarah Sacoor, Georgia R. Leisegang, et al.
Clinical Immunology (2023) Vol. 255, pp. 109700-109700
Closed Access | Times Cited: 1
Sarscov-2 Antibody Response to COVID-19 MRNA Vaccine in 2024 among Health Care Workers Working in one Selected Public Hospital from Myanmar
Khin Phyu Pyar, Aung Phyoe Kyaw, Kaung Myat Oo, et al.
International Journal of Medical Science and Clinical Research Studies (2024) Vol. 04, Iss. 08
Open Access
Comparison of Adverse Events and Antibody Responses Among Different COVID-19 Vaccination Schedules
Ana Carolina Matias Dinelly Pinto, Maria Francilene Souza Silva, Fátima de Cássia Evangelista de Oliveira, et al.
Viral Immunology (2024) Vol. 37, Iss. 7, pp. 337-345
Closed Access
The levels of SARS-CoV-2 IgG antibody and cytokine profile in blood serum of young people during the COVID-19 pandemic
Yu. А. Li, M. N. Dmitrachenko, E. V. Markelova, et al.
Medical Immunology (Russia) (2024) Vol. 27, Iss. 2, pp. 369-378
Open Access
Association between antibody responses post-vaccination and severe COVID-19 outcomes: national population-based cohort study in Scotland
C. M. Macdonald, Norah Palmateer, Andrew McAuley, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland
C. M. Macdonald, Norah Palmateer, Andrew McAuley, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top